Optimization of Cardiac Pacing Using CardioMEMS

Status unconfirmed · Has a placebo group

Conditions studied: Heart Failure

In brief

This study is designed to determine if a simplified technique for cardiac device reprogramming using pulmonary artery pressure (PAP) data in the acute setting holds promise to improve subjective assessments of patient quality of life (QOL), objective measurements of functional capacity, and specific systolic and diastolic echocardiographic indices.

Key facts

Study ID

NCT03581032

Run by

St. Francis Hospital, New York

People needed

30

Starts

2017-03-01

Expected to finish

2019-06-01

Last updated by the study team

2018-07-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients have implanted PPM, ICD, or CRT devices and CardioMEMS
• Patients can ambulate for 6 minutes and lay on a flat surface
• Patients are paced > 95% of the time
• Patients are not in acute CHF and are on a stable medication regimen
• Patients have adequate echocardiographic windows
• Patients can consent independently

You may not qualify if…

• Patients with poor echocardiographic acoustical resolution.
• Patients with congenital heart disease.
• Patients with mechanical aortic or mitral valve replacements.
• Patients with significant mitral annular calcification.
• Patients with irregular heart rates: atrial fibrillation, supraventricular tachycardia, atrial premature contractions, and ventricular arrhythmia that would preclude data acquisition.
• Patients unable to remain still secondary to movement disorders or agitation.
• Inpatient status
• Patients with poorly controlled HTN (SBP>160/90

Where it is running

• St Francis Hospital — Roslyn, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.